Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy study (2021)

First Author: Cann A
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.17231.1

Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.17231.1

Type: Journal Article/Review

Parent Publication: Wellcome Open Research